Moderna has reported positive phase 3 results for its seasonal flu vaccine, mRNA-1010, which outperformed a standard-dose ...

Moderna's mRNA flu vaccine showed 26.6% better efficacy than a standard flu shot in adults 50 and older during a global Phase ...

RNA-1010 demonstrated superior relative vaccine efficacy that was 26.6% (95% CI; 16.7%, 35.4%) higher than a licensed ...

An Australian man has died from an "extremely rare" rabies-like infection transmitted by a bat bite, health officials said ...

Moderna reports positive results from phase 3 efficacy study of P304 for seasonal influenza vaccine: Cambridge, Massachusetts Wednesday, July 2, 2025, 16:00 Hrs [IST] Moderna, Inc ...

Compared with flu vaccine recipients, those given the RSV or shingles vaccine had 18% to 37% lower odds of receiving a ...

The Trump administration's vaccine advisers are bringing up an old flu-shot debate: Whether it's time to wipe out the last ...

The administration's cuts to the Department of Health and Human Services are going to do irreparable harm to the nation’s ...

Kennedy's new vaccine advisory committee returned to work Thursday, and the panel may vote on proposals about fall flu ...

mRNA-1010 demonstrated superior relative vaccine efficacy that was 26.6% (95% CI; 16.7%, 35.4%) higher than a licensed standard-dose seasonal influenza vaccine in ... There were no significant ...

Could common viruses silently influence your brain health? Discover what new research reveals about herpes and dementia.

The following is the transcript of an interview with former FDA commissioner Scott Gottlieb, Pfizer board member and ...